iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Byrne Asset Management LLC

Byrne Asset Management LLC lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 21.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 667 shares of the financial services provider’s stock after selling 185 shares during the quarter. Byrne Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $88,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Huntington National Bank raised its position in shares of iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares in the last quarter. National Bank of Canada FI boosted its position in iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares during the last quarter. Avior Wealth Management LLC raised its holdings in iShares Biotechnology ETF by 438.2% in the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after acquiring an additional 2,629 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its position in iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after buying an additional 164,000 shares during the period. Finally, Main Management ETF Advisors LLC lifted its position in shares of iShares Biotechnology ETF by 2.5% in the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after acquiring an additional 14,535 shares during the period. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 2.1 %

IBB stock opened at $137.67 on Friday. The business has a fifty day moving average price of $136.22 and a 200 day moving average price of $141.41. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.